Old wine in new bottles: low-tech approaches to a COVID-19 vaccine
27 January 2021
By David Berd, Chief Medical Officer, BioVaxys. It has been a little more than a year since COVID-19 was released on the world causing widespread respiratory illness, death and major disruptions in the world’s economies and in people’s daily lives. From the beginning of the pandemic, it was recognised that a vaccine that prevented the acquisition […]